ACEA Therapeutics and ACEA Pharma to Acquire Phoenix Asia Holdings’ ACEA Pharma Stake in $1B Stock Deal
May 5, 2026
Scilex Holding Company’s indirect subsidiaries ACEA Therapeutics, Inc. and ACEA Pharma, Inc. entered into a stock acquisition agreement with Phoenix Asia Holdings Limited to acquire 100% of ACEA Pharma. The transaction is valued at $1 billion and will issue Phoenix shares to ACEA Therapeutics, with Phoenix expected to be renamed the “Go-Forward Company” ACEA Pharma and listed on Nasdaq after closing.
- Buyers
- ACEA Therapeutics, Inc., ACEA Pharma, Inc.
- Targets
- ACEA Pharma, Inc.
- Sellers
- Phoenix Asia Holdings Limited
- Industry
- Pharmaceuticals
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.